Drug Type Synthetic peptide |
Synonyms- |
Target |
Mechanism KIF20A antagonists(kinesin family member 20A antagonists) |
Therapeutic Areas- |
Active Indication- |
Inactive Indication- |
Originator Organization- |
Active Organization- |
Inactive Organization- |
Drug Highest PhaseClinical |
First Approval Date- |
Regulation- |
Molecular FormulaC60H105N17O12 |
InChIKeyLYBZGRBEJKCFJH-BHEJXMHWSA-N |
CAS Registry1049674-65-8 |